Molecular immunohaematology round table discussions at the AABB Annual Meeting, Anaheim 2015.

Competing Interests: of conflicts of interest CAT holds a research grant from Terumo BCT. FFW and WAF are inventors of patents owned by the German Red Cross Blood Service Baden-Württemberg-Hessen. GAD is the inventor of patents on red cell genotyping owned by the Canadian Blood Services and on the speakers’ bureau of Grifols. GS receives research support from Immucor. LC is on the Transfusion Advisory Board of Grifols. MAK is on the speakers’ bureau of Agena Bioscience. WAF holds intellectual property rights for RHD genotyping applications. WALH is a consultant for Cerus Corporation and Seres Therapeutics. WJL receives support from Wiley Publishing for educational activities related to the Transfusion News Question of the Day. The remaining authors declared that they have no competing financial interests relevant to this article.